CONSORT MEDICAL LIMITED
Get an alert when CONSORT MEDICAL LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-11-24 (in 6mo)
Last made up 2025-11-10
Watchouts
None on the register
Cash
£3M
+106,933.3% vs 2023
Net assets
£226M
+12.6% vs 2023
Employees
0
Average over period
Profit before tax
-£11M
-208.3% vs 2023
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | — | — | |
| Operating profit | £10,754,000 | -£10,626,000 | |
| Profit before tax | £10,613,000 | -£11,499,000 | |
| Net profit | £10,892,000 | -£10,047,000 | |
| Cash | £3,000 | £3,211,000 | |
| Total assets less current liabilities | £200,925,000 | £226,253,000 | |
| Net assets | £200,925,000 | £226,253,000 | |
| Equity | £200,925,000 | £226,253,000 | |
| Average employees | 0 | 0 | |
| Wages | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Return on capital employed | 5.4% | -4.7% | |
| Gearing (liabilities / total assets) | 38.3% | 16.5% | |
| Current ratio | 0.04x | 0.14x | |
| Interest cover | 1.34x | -1.22x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- FRS 101
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“the directors are confident that the company will have sufficient funds to continue to meet its liabilities as they fall due for the review period to 31 December 2026 and therefore have prepared the financial statements on a going concern basis.”
Group structure
- CONSORT MEDICAL LIMITED · parent
- Consort Medical Holdings Limited 100%
- Aesica Queenborough Ltd 100%
- Consort Medical Srl 100%
- Aesica Pharmaceuticals SRL 100%
- Consort Medical GmbH 100%
- Aesica Pharmaceuticals GmbH 90%
Significant events
- “Subsequent to the balance sheet date, a series of group restructuring transactions have taken place to tidy up the intercompany balances between the Company and Consort Medical GmbH.”
- “Subsequent to the balance sheet date, the UK group relief balances (existing at 31 December 2024) have been settled between the carve out entities, Bespak Europe Limited, Bespak HC Limited and Bespak Limited (Bespak).”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
3 active · 58 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| DAWSON, Andrew Robert Anthony | Director | 2023-02-01 | Jan 1980 | British |
| GRAND, Emmanuel Nicolas | Director | 2024-04-01 | Feb 1974 | Swiss |
| HOLLOWAY, Guenaelle | Director | 2024-04-01 | Nov 1973 | French |
Show 58 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ALLNUTT, Robert Edward Bruce | Secretary | 2009-02-27 | 2009-10-30 |
| COTTON, Richard John | Secretary | 2014-04-30 | 2014-07-15 |
| HAYES, Paul Andrew | Secretary | 2018-02-28 | 2018-09-07 |
| ILETT, John Edward | Secretary | 2015-11-02 | 2018-02-28 |
| JACKSON, Andrew Leonard | Secretary | 2018-09-07 | 2020-04-30 |
| KERBEY, David Terence | Secretary | — | 1997-07-01 |
| LOBO, Matthew Joseph Edwin | Secretary | 2005-10-01 | 2006-03-08 |
| OWEN, Jennifer Margaret | Secretary | 2006-03-08 | 2009-02-27 |
| SAUNBY, Tracy | Secretary | 2020-04-30 | 2020-07-31 |
| SCOTT, Alexandra Louise | Secretary | 1997-07-01 | 2005-09-30 |
| SLATER, John | Secretary | 2009-11-02 | 2014-04-30 |
| WARD, Iain Stuart | Secretary | 2014-07-15 | 2015-11-02 |
| ALTMAN, William P | Director | 1993-09-24 | 1998-01-31 |
| AUER, Adrian Richard | Director | 2005-04-01 | 2006-04-26 |
| BANKS, Christopher John | Director | 2006-04-26 | 2012-08-30 |
| BARR, Robert George | Director | 1996-04-29 | 1999-10-29 |
| BOUGHTON, Paul Victor | Director | 2006-06-01 | 2009-12-10 |
| BRINSMEAD, Christopher David | Director | 2019-02-07 | 2020-02-04 |
| CASHMAN, John Patrick | Director | 2002-09-20 | 2006-09-28 |
| CHAMBRE, Peter Alan | Director | 1994-03-09 | 2000-07-29 |
| CHISHOLM, John Alexander Raymond, Sir | Director | 1999-09-10 | 2005-09-08 |
| COOKSEY, David James Scott, Sir | Director | 1993-12-21 | 2004-01-20 |
| COTTON, Richard John | Director | 2012-06-25 | 2016-12-13 |
| CRUMMETT, Stephen Paul | Director | 2012-06-13 | 2020-02-04 |
| DICK, James Lawrence | Director | 2006-04-26 | 2012-08-30 |
| DRUMMOND, Lynn, Dr | Director | 2011-02-09 | 2014-07-14 |
| DUNNE, Patrick Joseph | Director | — | 1996-03-29 |
| ELDERED, Thomas Bengt | Director | 2020-02-04 | 2021-03-15 |
| FELLNER, Peter John, Dr | Director | 2005-11-14 | 2019-04-24 |
| FITZWILLIAMS, Duncan John Lloyd | Director | — | 1999-09-10 |
| GINMAN, Maria Charlotta | Director | 2015-02-11 | 2020-02-04 |
| GLENN, Jonathan Martin | Director | 2006-09-11 | 2020-02-04 |
| HAYES, Paul Andrew | Director | 2017-05-01 | 2020-02-04 |
| HICKS, Alun George | Director | — | 1994-09-23 |
| HIGGINS, Nicolas Andrew | Director | 2011-01-01 | 2013-02-28 |
| HILAIRE, Jean-Francois | Director | 2021-03-15 | 2022-11-01 |
| HIRST, Christopher Anthony | Director | 2022-11-01 | 2024-04-01 |
| HOPCROFT, Martin Peter | Director | 2002-11-05 | 2006-07-26 |
| HOSTY, Andrew Joseph, Dr | Director | 2014-07-14 | 2020-02-04 |
| JENKINS, William John, Dr | Director | 2009-05-06 | 2020-02-04 |
| KENNEDY, George Macdonald | Director | 2006-08-29 | 2011-09-01 |
| KING, Robert Harmer | Director | — | 1995-09-06 |
| KLUG, Oren | Director | 2022-03-15 | 2024-04-01 |
| LILLEY, John | Director | — | 1996-05-31 |
| LODGE, Lisa | Director | 2022-05-06 | 2023-02-01 |
| MANN, Roger | Director | 1997-01-31 | 2001-09-21 |
| MEREDITH, William George | Director | 2000-07-04 | 2006-09-28 |
| NICHOLSON, Ian James | Director | 2012-06-13 | 2020-02-04 |
| PREECE, Robert John | Director | 1995-04-03 | 2002-11-05 |
| QUICK, Mark Royston | Director | 2020-02-04 | 2022-03-15 |
| ROBINSON, John Harris | Director | 2004-01-20 | 2009-04-30 |
| ROXIN, Daniela Sylvia Beate, Dr. | Director | 2021-05-01 | 2022-11-01 |
| SCHUMANN, Andrew Anthony | Director | — | 2000-09-22 |
| SCHUMANN, Michael Alec | Director | — | 1993-09-01 |
| TALBOT, Michael Alan | Director | — | 1999-04-30 |
| TAYLOR, Paul | Director | 2000-07-04 | 2002-07-31 |
| THRODAHL, Mark Crandall | Director | 2001-06-07 | 2007-12-05 |
| WOOLRYCH, Toby Richard | Director | 2008-10-01 | 2012-06-25 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Recipharm Uk Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2020-03-06 | Active |
Filing timeline
Last 20 of 582 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-12-19 | AA | accounts | Accounts with accounts type full | |
| 2025-12-09 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2025-11-17 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2025-06-24 | SH19 | capital | Capital statement capital company with date currency figure | |
| 2025-06-24 | SH20 | capital | Legacy | |
| 2025-06-24 | CAP-SS | insolvency | Legacy | |
| 2025-06-24 | RESOLUTIONS | resolution | Resolution | |
| 2025-03-20 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2024-12-06 | AD01 | address | Change registered office address company with date old address new address | |
| 2024-08-12 | AA | accounts | Accounts with accounts type full | |
| 2024-04-22 | SH01 | capital | Capital allotment shares | |
| 2024-04-09 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-09 | AP01 | officers | Appoint person director company with name date | |
| 2024-04-09 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-09 | TM01 | officers | Termination director company with name termination date | |
| 2024-04-09 | MR04 | mortgage | Mortgage satisfy charge full | |
| 2024-04-03 | MR04 | mortgage | Mortgage satisfy charge part | |
| 2024-03-15 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-10-16 | AA | accounts | Accounts with accounts type full | |
| 2023-03-10 | CS01 | confirmation-statement | Confirmation statement with no updates |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 7
- Capital events
- 2
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
—
Not reported
-
Cash
+106,933.3%
£3,000 £3,211,000
-
Net assets
+12.6%
£200,925,000 £226,253,000
-
Employees
—
Not reported
-
Operating profit
-198.8%
£10,754,000 -£10,626,000
-
Profit before tax
-208.3%
£10,613,000 -£11,499,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. Periods don't have to be exactly 12 months apart — a long or short period (typical around incorporation or year-end changes) will distort the comparison. Lines a company doesn't report are omitted. About these numbers